Cas:68870-58-6 Methyl 3-(4-chlorophenyl)-5-methylisoxazole-4-carboxylate manufacturer & supplier

Chemical Name:Methyl 3-(4-chlorophenyl)-5-methylisoxazole-4-carboxylate

CAS.NO:68870-58-6

Synonyms:(3-(4-chlorophenyl)-5-methyl)isoxazole-4-carboxylic acid ethyl ester;5-Methyl-4-methoxycarbonyl-3-(4-chlor-phenyl)-isoxazol;5-Methyl-4-aethoxycarbonyl-3-(4-chlor-phenyl)-isoxazol;3-(4-chloro-phenyl)-5-methyl-isoxazole-4-carboxylic acid methyl ester;ethyl 3-(4-chlorophenyl)-5-methylisoxazole-4-carboxylate;methyl 3-(p-chlorophenyl)-5-methylisoxazole-4-carboxylate;3-(4-Chlor-phenyl)-5-methyl-isoxazol-4-carbonsaeure-aethylester

Molecular Formula:C₁₂H₁₀ClNO₃

Molecular Weight:251.66600

HS Code:2934999090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:52.33000

Exact Mass:251.03500

LogP:3.09000

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (3-(4-chlorophenyl)-5-methyl)isoxazole-4-carboxylic acid ethyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-(4-Chlor-phenyl)-5-methyl-isoxazol-4-carbonsaeure-aethylester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(3-(4-chlorophenyl)-5-methyl)isoxazole-4-carboxylic acid ethyl ester Use and application,5-Methyl-4-methoxycarbonyl-3-(4-chlor-phenyl)-isoxazol technical grade,usp/ep/jp grade.

Related News: J.P. Morgan and William Blair analysts still backed iRhythm for the long-term despite its recent challenges. William Blair analysts wrote that the company is still a leader of a cardiac monitoring market that is under 20% penetrated and valued at approximately $2 billion. 7-phenylmethoxy-2,3-dihydro-1H-indole manufacturers A possible reason for this is that developments within the biocatalysis field have fast outpaced existing knowhow, leaving some pharmaceutical companies unaware of the vast range of options available. Keeping abreast of both current and emerging developments within the field of biocatalytic processing is key when it comes to maintaining a competitive edge. 4-bromo-5-methylthiazole suppliers In addition, AstraZeneca is exploring the potential of anifrolumab in a variety of diseases where type I interferon plays a key role, including lupus nephritis, cutaneous lupus erythematosus and myositis. Boc-isonipecotic acid vendor & factory.